Abstract:A series of novel structurally-related tubulin polymerization inhibitors based on benzodiazepine were designed, synthesized, and evaluated for anticancer activity. Extensive structure modifications were performed to investigate the detailed structure and activity relationships (SARs). Most compounds exhibited potent antiproliferative activity against a panel of cancer cell lines. Among these compounds, the optimal compound, 9a, possessed the most superior activity, including cytotoxicity against five cancer cell lines (IC50 = 6-15 nM) and inhibition of tubulin polymerization (IC50= 1.65 +/- 0.11 mu M). Mechanistic studies revealed that 9a could disrupt intracellular microtubule organization, arrest cell cycle at the G(2)/M phase and eventually induce cell apoptosis. Compound 9a exhibited good metabolic stability with a t(1/2) of 161.2 min, which was much better than the reference compound CA-4. Moreover, the disodium salt of 9a, 9a-P, exhibited excellent in vivo antitumor activity in xenograft mice model with inhibitory rate of 893%, which was better than the reference compounds CA-4P (inhibitory rate: 52.8%) and Y-01P (inhibitory rate: 77.7%). Altogether, 9a could serve as a promising lead compound for the development of highly efficient anticancer agents. (C) 2019 Elsevier Masson SAS. All rights reserved.

Design and Synthesis of Brazilin-LikeCompounds

Design, Synthesis, and Anticancer Activity Evaluation of Hybrids of Azoles and Barbituric Acids.

Design, Synthesis and Cytotoxic Activity of Novel Hybrid Compounds Between Aza-brazilin and Imidazolium

Synthesis and Antitumor Activity of Aza-Brazilan Derivatives Containing Imidazolium Salt Pharmacophores

Design, Synthesis and Biological Evaluation of Novel Hybrid Compounds of Imidazole Scaffold-Based 2-Benzylbenzofuran As Potent Anticancer Agents

Design, Synthesis, and Antitumor Activity of (E,Z)-1-(dihydrobenzofuran-5-yl)-3-phenyl-2-(1,2,4-triazol-1-yl)-2-propen-1-ones.

Synthesis of Aza-brazilin/diarylindan-Based Hybrid

Design, Synthesis And Biological Evaluation Of Novel Bromophenol Derivatives Incorporating Indolin-2-One Moiety As Potential Anticancer Agents

Chemoenzymatic formal synthesis of (+)-brazilin

Design, Synthesis, and Biological Evaluation of the Novel Glycyrrhetinic Acid-Cinnamoyl Hybrids As Anti-Tumor Agents

Design and synthesis of novel 5,6-disubstituted pyridine-2,3-dione-3-thiosemicarbazone derivatives as potential anticancer agents.

Synthesis, biological evaluation and mechanism study of a class of benzylideneindanone derivatives as novel anticancer agents

Discovery of Novel 1,5-Benzodiazepine-2,4-dione Derivatives As Potential Anticancer Agents.

Design, Synthesis and Antiproliferative Activities Evaluation of Thiazolopyrimidines Derivatives Through Biginelli Reaction

Design, Synthesis, In Vitro Evaluation of New Tetrahydrooxazolo [5′,4′:4,5]Pyrimido[1,2‐a]Azepinone Derivatives as Anticancer Agents

Synthesis And Antitumor Activity Of 5-Bromo-7-Azaindolin-2-One Derivatives Containing A 2,4-Dimethyl-1h-Pyrrole-3-Carboxamide Moiety

Novel Benzothiazole, Benzimidazole and Benzoxazole Derivatives As Potential Antitumor Agents: Synthesis and Preliminary in Vitro Biological Evaluation

Design, Synthesis and Anticancer Activity of a New Series of N-aryl-N′-[4-(pyridin-2-ylmethoxy)benzyl]urea Derivatives

Design, Synthesis and Anticancer Activity of a New Series of <i>N</i>-aryl-<i>N</i>-[4-(pyridin-2-ylmethoxy)benzyl]urea Derivatives

Design, Synthesis and Biological Evaluation of N-arylsulfonyl Carbazoles As Novel Anticancer Agents

Design, Synthesis, and Biological Evaluation of Novel Benzodiazepine Derivatives As Anticancer Agents Through Inhibition of Tubulin Polymerization in Vitro and in Vivo